Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Objective To assess serum lipid and lipoprotein concentrations and oral glucose tolerance in postmenopausal women treated with 17β‐oestradiol (2 mg/day) and cyclical dydrogesterone (10 mg/day for 14 days per 28 day cycle). Design A 24 month prospective study of 29 women acting as their own controls. On‐treatment samples were taken during the combined (oestrogen–progestogen) phase of therapy. Setting Metabolic research unit in London. Population Postmenopausal women with no previous exposure to hormone replacement therapy attending a menopause clinic in a London hospital. Methods Fasting serum sampling and oral glucose tolerance testing. Main outcome measures Serum lipids and lipoprotein concentrations and plasma glucose, insulin and C‐peptide responses to an oral glucose load. Results Restricting the analysis to the 17 women who completed the study, no effect was seen on serum triglyceride concentrations. There was a mean fall of 5.9% (95% CI 1.2 to −13.0) in concentrations of serum total cholesterol, reflecting the balance of a 10.7% fall (95% CI 4.3 to −25.8) in low density lipoprotein cholesterol concentrations and a 16.3% increase (95% CI 7.3 to −25.3) in those of high density lipoproteins. Fasting glucose concentrations and glucose tolerance test responses were unchanged. Fasting insulin concentrations fell substantially (–41.6%, 95% CI −23.4 to −59.8) with falls also being seen in insulin responses to glucose. Fasting C‐peptide concentrations increased by 36.2% (95% CI 9.17 to 63.3), with no consistent effect on C‐peptide responses to glucose. Conclusions Dydrogesterone did not appear to oppose the potentially beneficial effects of oestradiol on insulin or either low or high density lipoproteins, making the combination with 17β‐oestradiol a potentially useful option for postmenopausal women particularly those at risk of cardiovascular disease or diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Walsh, B. W., Schiff, I., Rosner, B., Greenberg, L., Ravnikar, V., & Sacks, F. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251702 · Cited by 1,152
JACOBS, D. R., MEBANE, I. L., BANGDIWALA, S. I., CRIQUI, M. H., TYROLER, H. A., & PROGRAM, F. T. L. R. C. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115483 · Cited by 452
Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232003 · Cited by 417
Self-citation
Cited by
for the Women’s Health Initiative Investigators, Margolis, K. L., Bonds, D. E., Rodabough, R. J., Tinker, L., Phillips, L. S., Allen, C., Bassford, T., Burke, G., Torrens, J., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1448-x · Cited by 599
“Some of the variation in the results in intermediate endpoints reviewed above may be due to the following: (i) the small number of women included [4, 6, 11, 13, 14, 16, 17, 18, 20, 37, 38]; (ii) the short duration of the trial [6, 16, 17, 20, 42, 44]; (iii) the use of a higher dose of conjugated equine oestrogens [11,…”
BackgroundResultGodsland, I. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01699-5 · Cited by 370
Self-citationMauvais-Jarvis, F., Manson, J. E., Stevenson, J. C., & Fonseca, V. A. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1146 · Cited by 341
Self-citationFat and protein redistribution with aging: metabolic considerations
Beaufrère, B., & Morio, B. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601025 · Cited by 289
de Lauzon-Guillain, B., Fournier, A., Fabre, A., Simon, N., Mesrine, S., Boutron-Ruault, M.-C., Balkau, B., & Clavel-Chapelon, F. (2009) · Diabetologia · doi:10.1007/s00125-009-1456-y · Cited by 86
Metadata
- Authors
- Crook, D., Godsland, I. F., Hull, J., & Stevenson, J. C.
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 1997-03
- Volume
- 104
- Issue
- 3
- Pages
- 298-304
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- OpenAlex
- W2050847671
- Cited by
- 105
- References
- 4
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. https://app.cochat.ai/papers/10.1111/j.1471-0528.1997.tb11457.x
- The paper
- Crook, D., Godsland, I. F., Hull, J., & Stevenson, J. C. (1997). Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/j.1471-0528.1997.tb11457.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.